ISSN: 1859 - 2872
Effect of the dual trigger protocol for final follicular maturation for normal responders in IVF cycles
Main Article Content
Keywords
Abstract
Objective: To compare the results of the number of oocytes, the number of mature oocytes and the number of embryo between the two groups which are hCG (Human Chorionic Gonadotropin) alone group and hCG combined with GnRH agonist (GnRHa) in the group of patients who responded to the application. Subject and method: The study was conducted on 175 patients who met the intensity of just performing in vitro fertilization cycles at the Military Institute of clinical Embryology and Histology, Vietnam Military Medical University, divided into two groups. Result: Number of mature oocytes (7.56 ± 4.01 and 6.23 ± 3.13, p=0.015), number of fertilized oocytes (5.44 ± 3.57 and 4.29 ± 2.74, p=0.018), number of explosions on day 3 (4.92 ± 2.98 and 3.89 ± 2.38, p=0.012), number of invitations on day 5 (3.38 ± 2.44 and 2.52 ± 1.95, p=0.011), good number born on day 5 (1.48 ± 1.71 and 0.97 ± 1.41, p=0.030). Conclusion: Using the dual trigger increases the number of mature oocytes, the number of 2PN embryos and the number of day 3 embryos, blastocysts as well as good quality day 5 embryos compared to using hCG alone in normal ovarian responders.
Article Details
References
2. Humaidan P, Bredkjaer HE, Bungum L (2005) GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: A prospective randomized study. Hum Reprod 20(5): 1213–1220.
3. Haahr T, Roque M, Esteves SC (2017) GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG trigger and conventional luteal phase support in fresh embryo transfer IVF/ICSI Cycles-a systematic prisma review and meta-analysis. Front Endocrinol (Lausanne) 8: 116.
4. Shapiro BS, Daneshmand ST, Garner FC (2008) Gonadotropin-releasing hormone agonist combined with a reduced dose of human chorionic gonadotropin for final oocyte maturation in fresh autologous cycles of in vitro fertilization. Fertil Steril 90(1): 231-233.
5. Haas J, Bassil R, Samara N (2020) GnRH agonist and hCG (dual trigger) versus hCG trigger for final follicular maturation: A double-blinded, randomized controlled study. Hum Reprod 35(7): 1648-1654.
6. Namavar Jahromi B, Parsanezhad ME, Shomali Z (2018) Ovarian Hyperstimulation Syndrome: A Narrative Review of Its Pathophysiology, Risk Factors, Prevention, Classification, and Management. Iran J Med Sci 43(3): 248-260.
7. Breivik H, Borchgrevink PC, Allen SM (2008) Assessment of pain. Br J Anaesth 101(1): 17-24.
8. Lin MH, Wu FSY, Lee RKK (2013) Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles. Fertil Steril 100(5): 1296-1302.
9. Albeitawi S, Marar EA, Reshoud FA (2022) Dual trigger with gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves oocyte yield in normal responders on GnRH-antagonist cycles. JBRA Assist Reprod 26(1): 28-32.
10. Kim CH, Ahn JW, You RM (2014) Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization. J Reprod Med 59(1-2): 63-68.
Article Sidebar
